Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567749 · ClinicalTrials.gov registry record
Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population
A clinical trial, sponsored by Chembio Diagnostic Systems.
- Completed
- Registry status
- 10
- Enrollment target
NCT00567749: Completed study, sponsored by Chembio Diagnostic Systems.
NCT00567749 is a clinical trial that has completed, run by Chembio Diagnostic Systems. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00567749 has completed, sponsored by Chembio Diagnostic Systems.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in pediatric subjects who are between 12 and 17 years of age. A minimum of ten (10) known HIV-positive participants will be tested.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-06 |
What the finished NCT00567749 record still lists
NCT00567749 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00567749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00567749 about?
NCT00567749 is a clinical study titled "Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population". This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in pediatric subjects who are between 12 and 17 years of age. A minimum of ten (10) known HIV-positive participants...
What is the current status of trial NCT00567749?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2007-12. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00567749?
This trial is sponsored by Chembio Diagnostic Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia